Bio-gate AG (BIG1) — Cash Flow-to-Debt Ratio
Bio-gate AG (BIG1) has a Cash Flow-to-Debt Ratio of -0.56x as of December 2024, meaning its operating cash flow of €-1.22 Million could theoretically repay -1% of its total liabilities (€2.16 Million) in one year. See Bio-gate AG (BIG1) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Bio-gate AG Cash Flow-to-Debt Ratio (2020–2024)
Historical debt coverage capacity for Bio-gate AG across 5 annual periods. Also explore BIG1 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Bio-gate AG (2020–2024)
Year-by-year debt coverage analysis for Bio-gate AG. For market capitalisation and broader financial context, see Bio-gate AG (BIG1) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.56x | €-1.22 Million | €2.16 Million | ▼ -4.3% |
| 2023 | -0.54x | €-977.00K | €1.81 Million | ▲ +50.7% |
| 2022 | -1.10x | €-2.15 Million | €1.97 Million | ▼ -149.2% |
| 2021 | -0.44x | €-634.00K | €1.44 Million | ▼ -29.6% |
| 2020 | -0.34x | €-597.00K | €1.76 Million | — |